Insider Trading & Ownership of Charles A. Rowland Jr

Location: Furlong, PA
Summary: The estimated net worth of Charles A. Rowland Jr is at least $2,122,452 dollars as of 09 Feb 2026. Charles A. Rowland Jr is the Director of Viking Therapeutics, Inc. and owns shares of Viking Therapeutics, Inc. (VKTX) stock worth about $1.23M. Charles A. Rowland Jr is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp stock worth about $590.6K. Charles A. Rowland Jr is the Director of Generation Bio Co. and owns shares of Generation Bio Co. (GBIO) stock worth about $275.4K. Charles A. Rowland Jr is the Director of Nabriva Therapeutics plc and owns shares of Nabriva Therapeutics plc stock worth about $22.9K.
Signature: /s/ Shawna-Gay White, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Charles A. Rowland Jr files a new Insider Trading report.

Ownership of Charles A. Rowland Jr

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
VKTX	Viking Therapeutics, Inc.	Director	$1,233,511	-$2,134,278	-63%	02 Jan 2026
BPMC	Blueprint Medicines Corp	Director	$590,625			02 Jun 2021
GBIO	Generation Bio Co.	Director	$275,400			09 Feb 2026
NBRV	Nabriva Therapeutics plc	Director	$22,916			02 Aug 2021
ORTX	Orchard Therapeutics plc	Director				24 Jan 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.